University of PA Study Reveals Pembrolizumab Can Lengthen Progression-Free Survival in Non-Small Cell Lung Cancer

University of Pennsylvania investigators report that the administration of pembrolizumab behind locally ablative therapy (LAT) for oligometastatic non-small cell lung cancer (NSCLC) seems to lengthen progression-free survival (PFS) without degradation of quality of...

Singer With Cervical Cancer Seeks Access to Trial

Lorna Siggins writing for the Irish Times reports that Galway singer Áine Morgan believes immunotherapy drug Pembrolizumab can offer her a lifeline.  Morgan looks at the chance to participate in the Pembrolizumab trial as a chance at life. According to Siggins piece...

Pin It on Pinterest